Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS)

Médecine et maladies infectieuses
J ClarissouJ Salomon

Abstract

Despite a now codified antibiotic treatment for Lyme disease, a significant proportion of patients treated according to recommendations complain of persistent signs and symptoms. The pathophysiological mechanisms which underlie this syndrome of post-treatment chronic systemic illness remain unclear. For some physicians post-treatment symptoms indicate a persistent infection requiring prolonged antibiotic therapy. For others, there is no benefit from antimicrobial therapy. The difficulty of assessment encountered in studies is significant because many symptoms are subjective. We think that the term "chronic Lyme disease" is not appropriate and should be replaced by chronic "tick associated poly-organic syndrome" (TAPOS). This open-label prospective study was made on a group of 100 patients having followed a medical treatment for a chronic TAPOS and to evaluate their evolution under prolonged antibiotic treatment. The medical management was found to be effective for symptoms, especially for patients with a high probability of chronic TAPOS (NEJM score). Patients with post tick-bite symptoms, which often worsens their quality of life, deserve particular attention. This study had methodological limitations but could help in terms o...Continue Reading

References

May 15, 1991·Annals of Internal Medicine·C B Becker, D H Trock
Jan 1, 1989·Reviews of Infectious Diseases·G J Dammin
Jul 1, 1993·Clinics in Dermatology·W Burgdorfer
Jul 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S T Donta
Jul 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E AbererM Silberer
May 1, 1998·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·I Saint GironsD Postic
Jul 15, 1999·JAMA : the Journal of the American Medical Association·G P WormserR B Nadelman
Jan 11, 2001·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Dh teM V Assous
Feb 5, 2002·Journal of Clinical Microbiology·Kurt D Reed
Feb 21, 2002·The Journal of Experimental Medicine·Fang Ting LiangMario T Philipp
Jul 10, 2002·International Microbiology : the Official Journal of the Spanish Society for Microbiology·O Brorson, S H Brorson
Jul 16, 2002·Current Opinion in Rheumatology·Arthur Weinstein, Michael Britchkov
Aug 22, 2002·Clinical Rheumatology·H DejmkováP Vavrík
Jun 5, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T G BergerA Gessner
Feb 14, 2004·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R Murgia, M Cinco
May 19, 2004·International Journal of Medical Microbiology : IJMM·Franc Strle
Jun 25, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S K Singh, H J Girschick
Dec 29, 2004·Autoimmunity·Devin D Bolz, Janis J Weis
Jul 26, 2005·International Journal of Epidemiology·Victoria Cairns, Jon Godwin
Jun 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul G Auwaerter
Jul 17, 2007·International Journal of Antimicrobial Agents·Jean-Marc RolainDidier Raoult
Oct 5, 2007·The New England Journal of Medicine·Henry M FederL Zemel

❮ Previous
Next ❯

Citations

Nov 8, 2013·Postgraduate Medical Journal·Simon W DubreyWojtek Rakowicz
Jan 5, 2017·Infectious Diseases·Violeta T BriciuMihaela Lupşe
Sep 26, 2020·Frontiers in Medicine·Nevena ZubcevikLisa J Wood
Mar 31, 2016·The New England Journal of Medicine·Anneleen BerendeBart Jan Kullberg
May 11, 2018·Future Microbiology·Alexis LacoutChristian Perronne
Feb 16, 2019·Médecine et maladies infectieuses·S Ranque-GarnierA Donnet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Babesiosis (ASM)

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.